On Wednesday, March 26, the Sant Pau Research Institute (IR Sant Pau) hosted the conference about technological advancements for manufacturing in a Good Manufacturing Pratice (GMP) environment, a specialized event held as part of the Advanced Therapies Network (TERAV). The technically focused meeting spotlighted recent progress in equipment and processes used in the production of advanced therapies under GMP conditions.
The full-day session featured a packed, highly specialized agenda and included participation from leading companies and research centers such as SONY, SCINUS, and Applied Cells — all represented by Palex — as well as the Vall d’Hebron Institute of Oncology (VHIO), Hospital Clínic de Barcelona, and the Blood and Tissue Bank. The event showcased cutting-edge technologies including high-efficiency, column-free immunomagnetic cell isolation platforms, GMP-compliant cell sorting systems, and fully controlled bioreactors for the expansion of both adherent and suspension cells.
Throughout the day, critical aspects of cell production in GMP environments were addressed through practical case studies and real-world experiences shared by experts from leading clinical centers. This hands-on approach encouraged knowledge exchange among professionals involved in the development, manufacturing, and clinical application of advanced therapies.
Notably, the coordinator of the TERAV Network’s technology platforms specifically selected Sant Pau as the host site for this event, choosing it over several alternatives. This decision highlights the recognition of IR Sant Pau’s track record and commitment to the field of advanced therapies, as well as its leadership in infrastructure and expertise for driving projects in this area.
By hosting this event, Sant Pau strengthens its role as a reference center for innovation, translational research, and technology transfer in healthcare. These kinds of initiatives help foster collaboration among public research institutions, clinical organizations, and industry, while underscoring the development potential of Catalonia’s biomedical research system.
The TERAV Network is a scientific and technological initiative supported by the Spanish Ministry of Science, Innovation, and Universities. It aims to coordinate and enhance existing capabilities in advanced therapies across Spain. The network brings together research groups, technology platforms, and infrastructures working in areas such as gene therapy, cell therapy, and regenerative medicine, promoting collaboration, specialized training, and the development of joint projects.
